Status:
COMPLETED
Effects of Long Biliopancreatic Limb vs. Long Alimentary Limb in Superobesity, a Randomized Study
Lead Sponsor:
Aleris Obesity
Conditions:
Morbid Obesity
Weight Loss
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
Super Obesity, i.e. a BMI above 50, is difficult to treat. Normal gastric bypass surgery is not always enough for proper weight control. Bypassing a longer segment of the gut may be more beneficial. W...
Detailed Description
Two variations of gastric bypass are compared: Method 1 (test method):A 200 cm BP-limb (distance Treitz to EA) + 150 cm common channel (EA to ileocecal valve) + Roux-Y-limb variable Method 2 (standar...
Eligibility Criteria
Inclusion
- BMI 50-65
- Age 18-55
- Conservative attempts at weight reduction failed
Exclusion
- Inability to speak and understand the Swedish language
- Residence outside the county of Skåne
- Psychotic disease
- Inflammatory bowel disease
Key Trial Info
Start Date :
August 29 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2020
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT01514799
Start Date
August 29 2011
End Date
February 1 2020
Last Update
February 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aleris Obesity Skåne
Lund, Sweden, SE 222 70